查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球代謝組學市場研究報告 - 行業分析、規模、佔有率、成長、趨勢及2023年至2030年預測
市場調查報告書
商品編碼
1306545

全球代謝組學市場研究報告 - 行業分析、規模、佔有率、成長、趨勢及2023年至2030年預測

Global Metabolomics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日期: | 出版商: Value Market Research | 英文 221 Pages | 商品交期: 最快1-2個工作天內

價格

預計到2030年，全球代謝組學市場需求將從2022年的38.9億美元成長至118.2億美元，2023-2030年復合年成長率為14.9%。

代謝組學是一個科學研究領域，重點關注生物系統內小分子（稱為代謝物）的綜合分析和測量。它旨在鑑定和量化生物樣本（如血液、尿液、組織或細胞）中的代謝物，並了解它們在不同生物過程中的作用。通過對代謝物的分析，可以深入了解生物體的代謝狀態、生化變化和整體生理狀況。

市場動態：

質譜和核磁共振光譜等分析技術的進步擴大了代謝組學分析的能力和靈敏度，推動了其在研究和應用領域的需求。向個性化醫療的轉變催生了對患者代謝組進行全面分析的需求。這項研究在確定與疾病相關的獨特代謝特徵、實現早期診斷、患者分層和個性化治療方法方面發揮著至關重要的作用。對疾病檢測、預後和治療監測所需的準確生物標記的需求也推動了代謝組學的應用。代謝組學可用於製藥和生物技術行業的藥物研發。它有助於了解藥物代謝、確定藥物靶點和評估藥物安全性，有助於最佳化藥物開發過程和患者治療效果。代謝組學應用於農業和食品科學，有助於作物改良、食品品質評估以及了解植物和微生物的新陳代謝。政府計劃、支持性資金和科學界的合作進一步推動了該市場的成長和應用。

研究涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰了解行業結構，評估全球競爭吸引力。此外，這些工具還對全球代謝組學市場的各個細分市場進行了全面評估。代謝組學行業的成長和趨勢為本研究提供了整體方法。

區域分析：

該部分涵蓋了區域前景，突出了北美、歐洲、亞太、拉丁美洲以及中東和非洲地區代謝組學市場的當前和未來需求。此外，該部分還重點分析了所有主要地區各個應用領域的需求、估計和預測。

該研究還涵蓋了市場主要參與者的綜合概況以及全球競爭格局的深入分析。代謝組學市場的主要參與者包括沃特世公司（美國）、安捷倫科技公司（美國）、島津公司（日本）、賽默飛世爾科技公司（美國）、丹納赫公司（美國）、布魯克公司（美國）、珀金埃爾默公司（美國）、默克公司（德國）、通用電氣醫療保健公司（美國）、日立高新技術公司（日本）。人類代謝組技術公司（日本）、LECO公司（美國）。 Metabolon, Inc.（美國）、Bio-Rad Laboratories（美國）、Scion Instruments（美國）、DANI Instruments SpA（義大利）、GL Sciences（日本）、SRI Instruments（美國）、Kore Technology Ltd. （英國）、JASCO.(英國)和JASCO公司(美國)(共20家公司)。這部分包括競爭格局的整體視圖，其中包括各種戰略發展，如關鍵併購、未來能力、合作夥伴關係、財務概況、合作、新產品開發、新產品上市和其他發展。

如果您有任何客製化要求，請聯繫我們。我們的研究團隊可以根據您的需求提供客製化服務。

目 錄

第一章：前言

  • 說明
    • 目標
    • 目標受眾
    • 獨特銷售主張（USP）和產品
  • 研究範圍
  • 研究方法
    • 市場調研流程
    • 市場調研方法

第二章：執行摘要

  • 市場亮點
  • 全球市場概況

第三章：代謝組學-行業分析

  • 簡介- 市場動態
  • 市場驅動因素
  • 市場限制因素
  • 市場機會
  • 行業趨勢
  • 波特五力分析
  • 市場吸引力分析
    • 按產品和服務分類的市場吸引力分析
    • 按生物資訊學工具和服務的市場吸引力分析
    • 按應用分類的市場吸引力分析
    • 按適應症分類的市場吸引力分析
    • 按最終用戶市場吸引力分析
    • 市場吸引力分析：按地區

第四章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料製造商列表
    • 主要原料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直接行銷
    • 間接行銷
    • 行銷管道發展趨勢

第五章：全球代謝組學市場分析：按產品和服務分類

  • 產品和服務概述
  • 歷史和預測數據
  • 按產品和服務分析
  • 代謝組學儀器
  • 分離工具（氣相色譜、高效液相色譜、超高效液相色譜、毛細管電泳）
  • 檢測工具（核磁共振（NMR）光譜、質譜（MS）、表面品質分析）

第六章：全球代謝組學市場分析：按生物資訊學工具和服務分類

  • 生物資訊學工具和服務概述
  • 歷史和預測數據
  • 生物資訊學工具和服務分析
  • 生物資訊學服務
  • 生物資訊學工具和數據庫

第七章：全球代謝組學市場分析：按應用分類

  • 應用概述
  • 歷史和預測數據
  • 應用分析
  • 生物標記發現
  • 藥物發現
  • 毒理學測試
  • 營養基因組學
  • 功能基因組學
  • 個性化醫療
  • 其他

第八章：全球代謝組學市場分析：按適應症分類

  • 按適應症概述
  • 歷史和預測數據
  • 按適應症分析
  • 癌症
  • 心血管疾病
  • 神經系統疾病
  • 代謝性疾病
  • 先天性代謝異常
  • 其他疾病

第九章：全球代謝組學市場分析：按終端用戶分類

  • 終端用戶概述
  • 歷史和預測數據
  • 終端用戶分析
  • 學術研究機構
  • 製藥和生物技術公司
  • 契約研究組織
  • 其他

第10章：全球代謝組學市場分析：按地域分類

  • 地區前景
  • 地區介紹
  • 北美銷售分析
    • 概述、歷史和預測數據銷售分析
    • 北美地區銷售分析
    • 北美各國銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概述、歷史和預測數據銷售分析
    • 歐洲銷售分析
    • 歐洲各國銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概述、歷史和預測數據銷售分析
    • 亞太地區細分市場銷售分析
    • 亞太地區各國銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳大利亞銷售分析
    • 亞太其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概述、歷史和預測數據銷售分析
    • 拉丁美洲各細分市場銷售分析
    • 拉丁美洲各國銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概述、歷史和預測數據銷售分析
    • 中東及非洲地區銷售分析
    • 中東及非洲國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東及非洲其他地區銷售分析

第十一章：代謝組學公司的競爭格局

  • 代謝組學市場競爭
  • 夥伴關係/合作/協議
  • 合併與收購
  • 新產品發布
  • 其他發展

第十二章：公司概況

  • 公司佔有率分析
  • 市場集中度
  • Waters Corporation (US)
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Agilent Technologies (US)
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Shimadzu Corporation (Japan)
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Thermo Fisher Scientific (US)
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Danaher Corporation (US)
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Bruker Corporation (US)
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • PerkinElmer (US)
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Merck KGaA (Germany)
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • GE Healthcare (US)
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Hitachi High- Technologies Corporation (Japan)
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Human Metabolome Technologies Inc. (Japan)
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • LECO Corporation (US)
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Metabolon Inc. (US)
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Bio-Rad Laboratories (US)
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Scion Instruments (US)
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • DANI Instruments SpA (Italy)
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • GL Sciences (Japan)
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • SRI Instruments (US)
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Kore Technology Ltd. (UK)
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • JASCO Inc. (US)
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展

注-在公司概況中，財務細節和近期發展視情況而定，如果是私營公司則可能不包括在內。

Product Code: VMR112111504

The global demand for Metabolomics Market is presumed to reach the market size of nearly USD 11.82 BN by 2030 from USD 3.89 BN in 2022 with a CAGR of 14.9% under the study period 2023 - 2030.

Metabolomics is a field of scientific study that focuses on the comprehensive analysis and measurement of small molecules, known as metabolites, within a biological system. It aims to identify and quantify metabolites present in biological samples, such as blood, urine, tissues, or cells, and to understand their roles in different biological processes. The analysis of metabolites provides valuable insights into the metabolic state, biochemical changes, and overall physiological condition of an organism.

MARKET DYNAMICS:

The advancements in analytical techniques, such as mass spectrometry and nuclear magnetic resonance spectroscopy, have expanded the capabilities and sensitivity of metabolomics analysis, driving its demand in research and applications. The shift towards personalized medicine has created a demand for comprehensive profiling of patients' metabolomes. The study plays a crucial role in identifying unique metabolic signatures associated with diseases, enabling early diagnosis, stratification of patients, and personalized treatment approaches. The need for accurate biomarkers for disease detection, prognosis, and therapeutic monitoring also fuels the adoption of metabolomics. It is used for drug discovery and development in the pharmaceutical and biotechnology industries. It aids in understanding drug metabolism, identifying drug targets, and assessing drug safety profiles, contributing to optimized drug development processes and patient outcomes. Metabolomics finds applications in agriculture and food science, contributing to crop improvement, food quality assessment, and understanding plant and microbial metabolism. Government initiatives, supportive funding, and collaborations within the scientific community further drive the growth and adoption of this market.

The research covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of metabolomics. The growth and trends of metabolomics industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the metabolomics market provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product & Service

  • Metabolomics Instruments
  • Separation Tools (Gas Chromatography, High-Performance Liquid Chromatography, Ultra-Performance Liquid Chromatography, Capillary Electrophoresis)
  • Detection Tools (Nuclear Magnetic Resonance (NMR) Spectroscopy, Mass Spectrometry (MS), Surface-Based Mass Analysis)

By Bioinformatics Tools And Services

  • Bioinformatics Services
  • Bioinformatics Tools And Databases

By Appication

  • Biomarker Discovery
  • Drug Discovery
  • Toxicology Testing
  • Nutrigenomics
  • Functional Genomics
  • Personalized Medicine
  • Other

By Indication

  • Cancer
  • Cardiovascular Disorders
  • Neurological Disorders
  • Metabolic Disorders
  • Inborn Errors Of Metabolism
  • Other

By End User

  • Academic And Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations
  • Other

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Metabolomics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the metabolomics market include Waters Corporation (US), Agilent Technologies (US), Shimadzu Corporation (Japan), Thermo Fisher Scientific (US), Danaher Corporation (US), Bruker Corporation (US), PerkinElmer (US), Merck KGaA (Germany), GE Healthcare (US), Hitachi High- Technologies Corporation (Japan). Human Metabolome Technologies, Inc. (Japan), LECO Corporation (US). Metabolon, Inc. (US), Bio-Rad Laboratories (US), Scion Instruments (US), DANI Instruments S.p.A. (Italy), GL Sciences (Japan), SRI Instruments (US), Kore Technology Ltd. (UK), and JASCO, Inc. (US) (Total 20 companies). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . METABOLOMICS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product & Service
    • 3.7.2 Market Attractiveness Analysis By Bioinformatics Tools And Services
    • 3.7.3 Market Attractiveness Analysis By Appication
    • 3.7.4 Market Attractiveness Analysis By Indication
    • 3.7.5 Market Attractiveness Analysis By End User
    • 3.7.6 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL METABOLOMICS MARKET ANALYSIS BY PRODUCT & SERVICE

  • 5.1 Overview by Product & Service
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Product & Service
  • 5.4 Metabolomics Instruments Historic and Forecast Sales by Regions
  • 5.5 Separation Tools (Gas Chromatography, High-Performance Liquid Chromatography, Ultra-Performance Liquid Chromatography, Capillary Electrophoresis) Historic and Forecast Sales by Regions
  • 5.6 Detection Tools (Nuclear Magnetic Resonance (NMR) Spectroscopy, Mass Spectrometry (MS), Surface-Based Mass Analysis) Historic and Forecast Sales by Regions

6 . GLOBAL METABOLOMICS MARKET ANALYSIS BY BIOINFORMATICS TOOLS AND SERVICES

  • 6.1 Overview by Bioinformatics Tools And Services
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Bioinformatics Tools And Services
  • 6.4 Bioinformatics Services Historic and Forecast Sales by Regions
  • 6.5 Bioinformatics Tools And Databases Historic and Forecast Sales by Regions

7 . GLOBAL METABOLOMICS MARKET ANALYSIS BY APPICATION

  • 7.1 Overview by Appication
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Appication
  • 7.4 Biomarker Discovery Historic and Forecast Sales by Regions
  • 7.5 Drug Discovery Historic and Forecast Sales by Regions
  • 7.6 Toxicology Testing Historic and Forecast Sales by Regions
  • 7.7 Nutrigenomics Historic and Forecast Sales by Regions
  • 7.8 Functional Genomics Historic and Forecast Sales by Regions
  • 7.9 Personalized Medicine Historic and Forecast Sales by Regions
  • 7.10. Other Historic and Forecast Sales by Regions

8 . GLOBAL METABOLOMICS MARKET ANALYSIS BY INDICATION

  • 8.1 Overview by Indication
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Indication
  • 8.4 Cancer Historic and Forecast Sales by Regions
  • 8.5 Cardiovascular Disorders Historic and Forecast Sales by Regions
  • 8.6 Neurological Disorders Historic and Forecast Sales by Regions
  • 8.7 Metabolic Disorders Historic and Forecast Sales by Regions
  • 8.8 Inborn Errors Of Metabolism Historic and Forecast Sales by Regions
  • 8.9 Other Historic and Forecast Sales by Regions

9 . GLOBAL METABOLOMICS MARKET ANALYSIS BY END USER

  • 9.1 Overview by End User
  • 9.2 Historical and Forecast Data
  • 9.3 Analysis by End User
  • 9.4 Academic And Research Institutes Historic and Forecast Sales by Regions
  • 9.5 Pharmaceutical & Biotechnology Companies Historic and Forecast Sales by Regions
  • 9.6 Contract Research Organizations Historic and Forecast Sales by Regions
  • 9.7 Other Historic and Forecast Sales by Regions

10 . GLOBAL METABOLOMICS MARKET ANALYSIS BY GEOGRAPHY

  • 10.1. Regional Outlook
  • 10.2. Introduction
  • 10.3. North America Sales Analysis
    • 10.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.3.2. North America By Segment Sales Analysis
    • 10.3.3. North America By Country Sales Analysis
    • 10.3.4. United State Sales Analysis
    • 10.3.5. Canada Sales Analysis
    • 10.3.6. Mexico Sales Analysis
  • 10.4. Europe Sales Analysis
    • 10.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.4.2. Europe by Segment Sales Analysis
    • 10.4.3. Europe by Country Sales Analysis
    • 10.4.4. United Kingdom Sales Analysis
    • 10.4.5. France Sales Analysis
    • 10.4.6. Germany Sales Analysis
    • 10.4.7. Italy Sales Analysis
    • 10.4.8. Russia Sales Analysis
    • 10.4.9. Rest Of Europe Sales Analysis
  • 10.5. Asia Pacific Sales Analysis
    • 10.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.5.2. Asia Pacific by Segment Sales Analysis
    • 10.5.3. Asia Pacific by Country Sales Analysis
    • 10.5.4. China Sales Analysis
    • 10.5.5. India Sales Analysis
    • 10.5.6. Japan Sales Analysis
    • 10.5.7. South Korea Sales Analysis
    • 10.5.8. Australia Sales Analysis
    • 10.5.9. Rest Of Asia Pacific Sales Analysis
  • 10.6. Latin America Sales Analysis
    • 10.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.6.2. Latin America by Segment Sales Analysis
    • 10.6.3. Latin America by Country Sales Analysis
    • 10.6.4. Brazil Sales Analysis
    • 10.6.5. Argentina Sales Analysis
    • 10.6.6. Peru Sales Analysis
    • 10.6.7. Chile Sales Analysis
    • 10.6.8. Rest of Latin America Sales Analysis
  • 10.7. Middle East & Africa Sales Analysis
    • 10.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.7.2. Middle East & Africa by Segment Sales Analysis
    • 10.7.3. Middle East & Africa by Country Sales Analysis
    • 10.7.4. Saudi Arabia Sales Analysis
    • 10.7.5. UAE Sales Analysis
    • 10.7.6. Israel Sales Analysis
    • 10.7.7. South Africa Sales Analysis
    • 10.7.8. Rest Of Middle East And Africa Sales Analysis

11 . COMPETITIVE LANDSCAPE OF THE METABOLOMICS COMPANIES

  • 11.1. Metabolomics Market Competition
  • 11.2. Partnership/Collaboration/Agreement
  • 11.3. Merger And Acquisitions
  • 11.4. New Product Launch
  • 11.5. Other Developments

12 . COMPANY PROFILES OF METABOLOMICS INDUSTRY

  • 12.1. Company Share Analysis
  • 12.2. Market Concentration Rate
  • 12.3. Waters Corporation (US)
    • 12.3.1. Company Overview
    • 12.3.2. Company Revenue
    • 12.3.3. Products
    • 12.3.4. Recent Developments
  • 12.4. Agilent Technologies (US)
    • 12.4.1. Company Overview
    • 12.4.2. Company Revenue
    • 12.4.3. Products
    • 12.4.4. Recent Developments
  • 12.5. Shimadzu Corporation (Japan)
    • 12.5.1. Company Overview
    • 12.5.2. Company Revenue
    • 12.5.3. Products
    • 12.5.4. Recent Developments
  • 12.6. Thermo Fisher Scientific (US)
    • 12.6.1. Company Overview
    • 12.6.2. Company Revenue
    • 12.6.3. Products
    • 12.6.4. Recent Developments
  • 12.7. Danaher Corporation (US)
    • 12.7.1. Company Overview
    • 12.7.2. Company Revenue
    • 12.7.3. Products
    • 12.7.4. Recent Developments
  • 12.8. Bruker Corporation (US)
    • 12.8.1. Company Overview
    • 12.8.2. Company Revenue
    • 12.8.3. Products
    • 12.8.4. Recent Developments
  • 12.9. PerkinElmer (US)
    • 12.9.1. Company Overview
    • 12.9.2. Company Revenue
    • 12.9.3. Products
    • 12.9.4. Recent Developments
  • 12.10. Merck KGaA (Germany)
    • 12.10.1. Company Overview
    • 12.10.2. Company Revenue
    • 12.10.3. Products
    • 12.10.4. Recent Developments
  • 12.11. GE Healthcare (US)
    • 12.11.1. Company Overview
    • 12.11.2. Company Revenue
    • 12.11.3. Products
    • 12.11.4. Recent Developments
  • 12.12. Hitachi High- Technologies Corporation (Japan)
    • 12.12.1. Company Overview
    • 12.12.2. Company Revenue
    • 12.12.3. Products
    • 12.12.4. Recent Developments
  • 12.13. Human Metabolome Technologies Inc. (Japan)
    • 12.13.1. Company Overview
    • 12.13.2. Company Revenue
    • 12.13.3. Products
    • 12.13.4. Recent Developments
  • 12.14. LECO Corporation (US)
    • 12.14.1. Company Overview
    • 12.14.2. Company Revenue
    • 12.14.3. Products
    • 12.14.4. Recent Developments
  • 12.15. Metabolon Inc. (US)
    • 12.15.1. Company Overview
    • 12.15.2. Company Revenue
    • 12.15.3. Products
    • 12.15.4. Recent Developments
  • 12.16. Bio-Rad Laboratories (US)
    • 12.16.1. Company Overview
    • 12.16.2. Company Revenue
    • 12.16.3. Products
    • 12.16.4. Recent Developments
  • 12.17. Scion Instruments (US)
    • 12.17.1. Company Overview
    • 12.17.2. Company Revenue
    • 12.17.3. Products
    • 12.17.4. Recent Developments
  • 12.18. DANI Instruments S.p.A. (Italy)
    • 12.18.1. Company Overview
    • 12.18.2. Company Revenue
    • 12.18.3. Products
    • 12.18.4. Recent Developments
  • 12.19. GL Sciences (Japan)
    • 12.19.1. Company Overview
    • 12.19.2. Company Revenue
    • 12.19.3. Products
    • 12.19.4. Recent Developments
  • 12.20. SRI Instruments (US)
    • 12.20.1. Company Overview
    • 12.20.2. Company Revenue
    • 12.20.3. Products
    • 12.20.4. Recent Developments
  • 12.21. Kore Technology Ltd. (UK)
    • 12.21.1. Company Overview
    • 12.21.2. Company Revenue
    • 12.21.3. Products
    • 12.21.4. Recent Developments
  • 12.22. JASCO Inc. (US)
    • 12.22.1. Company Overview
    • 12.22.2. Company Revenue
    • 12.22.3. Products
    • 12.22.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis by Product & Service (USD MN)
  • Metabolomics Instruments Market Sales by Geography (USD MN)
  • Separation Tools (Gas Chromatography, High-Performance Liquid Chromatography, Ultra-Performance Liquid Chromatography, Capillary Electrophoresis) Market Sales by Geography (USD MN)
  • Detection Tools (Nuclear Magnetic Resonance (NMR) Spectroscopy, Mass Spectrometry (MS), Surface-Based Mass Analysis) Market Sales by Geography (USD MN)
  • Analysis Market by Bioinformatics Tools And Services (USD MN)
  • Bioinformatics Services Market Sales by Geography (USD MN)
  • Bioinformatics Tools And Databases Market Sales by Geography (USD MN)
  • Analysis by Appication (USD MN)
  • Biomarker Discovery Market Sales by Geography (USD MN)
  • Drug Discovery Market Sales by Geography (USD MN)
  • Toxicology Testing Market Sales by Geography (USD MN)
  • Nutrigenomics Market Sales by Geography (USD MN)
  • Functional Genomics Market Sales by Geography (USD MN)
  • Personalized Medicine Market Sales by Geography (USD MN)
  • Other Market Sales by Geography (USD MN)
  • Analysis by Indication (USD MN)
  • Cancer Market Sales by Geography (USD MN)
  • Cardiovascular Disorders Market Sales by Geography (USD MN)
  • Neurological Disorders Market Sales by Geography (USD MN)
  • Metabolic Disorders Market Sales by Geography (USD MN)
  • Inborn Errors Of Metabolism Market Sales by Geography (USD MN)
  • Other Market Sales by Geography (USD MN)
  • Analysis by End User (USD MN)
  • Academic And Research Institutes Market Sales by Geography (USD MN)
  • Pharmaceutical & Biotechnology Companies Market Sales by Geography (USD MN)
  • Contract Research Organizations Market Sales by Geography (USD MN)
  • Other Market Sales by Geography (USD MN)
  • Global Metabolomics Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Metabolomics
  • Market Research Process
  • Market Research Methodology
  • Global Metabolomics Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product & Service
  • Market Attractiveness Analysis by Bioinformatics Tools And Services
  • Market Attractiveness Analysis by Appication
  • Market Attractiveness Analysis by Indication
  • Market Attractiveness Analysis by End User
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product & Service (USD MN)
  • Metabolomics Instruments Market Sales by Geography (USD MN)
  • Separation Tools (Gas Chromatography, High-Performance Liquid Chromatography, Ultra-Performance Liquid Chromatography, Capillary Electrophoresis) Market Sales by Geography (USD MN)
  • Detection Tools (Nuclear Magnetic Resonance (NMR) Spectroscopy, Mass Spectrometry (MS), Surface-Based Mass Analysis) Market Sales by Geography (USD MN)
  • Global Market Analysis by Bioinformatics Tools And Services (USD MN)
  • Bioinformatics Services Market Sales by Geography (USD MN)
  • Bioinformatics Tools And Databases Market Sales by Geography (USD MN)
  • Global Market Analysis by Appication (USD MN)
  • Biomarker Discovery Market Sales by Geography (USD MN)
  • Drug Discovery Market Sales by Geography (USD MN)
  • Toxicology Testing Market Sales by Geography (USD MN)
  • Nutrigenomics Market Sales by Geography (USD MN)
  • Functional Genomics Market Sales by Geography (USD MN)
  • Personalized Medicine Market Sales by Geography (USD MN)
  • Other Market Sales by Geography (USD MN)
  • Global Market Analysis by Indication (USD MN)
  • Cancer Market Sales by Geography (USD MN)
  • Cardiovascular Disorders Market Sales by Geography (USD MN)
  • Neurological Disorders Market Sales by Geography (USD MN)
  • Metabolic Disorders Market Sales by Geography (USD MN)
  • Inborn Errors Of Metabolism Market Sales by Geography (USD MN)
  • Other Market Sales by Geography (USD MN)
  • Global Market Analysis by End User (USD MN)
  • Academic And Research Institutes Market Sales by Geography (USD MN)
  • Pharmaceutical & Biotechnology Companies Market Sales by Geography (USD MN)
  • Contract Research Organizations Market Sales by Geography (USD MN)
  • Other Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the and are not limited to the TOC.